Multidrug-resistant high-risk Enterococcus faecium clones: can we really define them?

Int J Antimicrob Agents. 2021 Jan;57(1):106227. doi: 10.1016/j.ijantimicag.2020.106227. Epub 2020 Nov 15.

Abstract

Enterococcus faecium is a significant opportunistic human pathogen with a broad host range, including humans, farm animals, pets and wildlife. Specialised subpopulations have globally evolved towards a powerful and convergent adaption to the healthcare environment by acquiring a cocktail of key antimicrobial resistance and virulence genes, enabling them to thrive in the disturbed microbiota of hospitalised patients. These populations can also be found in different community reservoirs, but the relevance of their dispersal in non-human hosts is greatly unknown and is here discussed. This review provides a brief historical overview of what we have been considering E. faecium high-risk clones worldwide alongside the advances in strain typing technologies that have revolutionised our understanding of the genetic evolution of this species over the last three decades.

Keywords: Clade A1; Enterococcus faecium; Genetic capitalism; High-risk clones; Hospital-associated clones; WGS strain typing.

Publication types

  • Review

MeSH terms

  • Adaptation, Biological*
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Typing Techniques
  • Drug Resistance, Multiple, Bacterial*
  • Enterococcus faecium / classification*
  • Enterococcus faecium / drug effects*
  • Enterococcus faecium / isolation & purification
  • Evolution, Molecular*
  • Gram-Positive Bacterial Infections / epidemiology
  • Host-Pathogen Interactions
  • Humans
  • Microbial Sensitivity Tests
  • Virulence

Substances

  • Anti-Bacterial Agents